| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $116K | +819.0% |
| Cost of Revenue | $201K | +1780.8% |
| Gross Profit | -$86K | -4644.2% |
| R&D Expense | $475K | +383.4% |
| SG&A Expense | $3.1M | +78.1% |
| Operating Income | -$5.1M | -158.1% |
| Pre-tax Income | -$5.0M | -42.4% |
| Net Income | -$5.0M | -42.4% |
| EPS (Basic) | -$0.57 |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.1M | — |
| Accounts Receivable | $3K | — |
| Inventory | $98K | +108.9% |
| Current Assets | $6.8M | +4490.7% |
| Total Assets | $7.4M | +789.2% |
| Current Liabilities | $1.2M | -16.5% |
| Total Liabilities | $1.4M | -16.8% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.2M | -298.6% |
| Capital Expenditures | $154K | +9.5% |
| Investing Cash Flow | -$183K | -14.4% |
| Financing Cash Flow | $10.4M | +755.5% |
| Free Cash Flow | -$4.3M | -264.4% |
| +0.0% |
| Stockholders' Equity |
| $6.0M |
| +767.4% |